Insulin NovoNordisk Actrapid HM 100 IE/ml, Injektionslösung

7680446100354 CH-44610 Injektionslösung

Associated product:

INSULIN Actrapid HM 100 UI/ml flac 10 ml
Insulin NovoNordisk Actrapid HM 100 IE/ml, Injektionslösung
Insulin NovoNordisk Actrapid HM 100 IE/ml, Injektionslösung
1 / 2
google

Article details

Package size
1 x 10 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/07/2021
Patient information leaflet
Français
22/07/2021
Patient information leaflet
Italien
22/07/2021
Summary of Product Characteristics
Allemand
22/07/2021
Summary of Product Characteristics
Français
22/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.0 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 28.70
Specialties list
Yes
Generic
No
SL addition date: 15/03/1988

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
44610
Drug name
Insulin NovoNordisk Actrapid HM 100 IE/ml, Injektionslösung
Galenic form
LSPA
ATC Code
A10AB01
Authorization status
Z
Dispensing category
B
First authorization
22/08/1986
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
INSULIN Actrapid HM 100 UI/ml flac 10 ml
Description (DE)
INSULIN Actrapid HM 100 IE/ml Durchstf 10 ml
Market launch
22/08/1986
Narcotic (BTM)
No